Cyfuse Biomedical K.K. (4892.T)

JPY 982.0

(-1.01%)

Operating Income Summary of Cyfuse Biomedical K.K.

  • Cyfuse Biomedical K.K.'s latest annual operating income in 2023 was -697.43 Million JPY , down -64.07% from previous year.
  • Cyfuse Biomedical K.K.'s latest quarterly operating income in 2024 Q2 was -219.01 Million JPY , up 4.75% from previous quarter.
  • Cyfuse Biomedical K.K. reported an annual operating income of -425.08 Million JPY in 2022, down -702.37% from previous year.
  • Cyfuse Biomedical K.K. reported an annual operating income of 70.56 Million JPY in 2021, up 118.96% from previous year.
  • Cyfuse Biomedical K.K. reported a quarterly operating income of -229.94 Million JPY for 2024 Q1, down -35.88% from previous quarter.
  • Cyfuse Biomedical K.K. reported a quarterly operating income of -169.23 Million JPY for 2023 Q4, down -2.85% from previous quarter.

Annual Operating Income Chart of Cyfuse Biomedical K.K. (2023 - 2020)

Historical Annual Operating Income of Cyfuse Biomedical K.K. (2023 - 2020)

Year Operating Income Operating Income Growth
2023 -697.43 Million JPY -64.07%
2022 -425.08 Million JPY -702.37%
2021 70.56 Million JPY 118.96%
2020 -372.13 Million JPY 0.0%

Peer Operating Income Comparison of Cyfuse Biomedical K.K.

Name Operating Income Operating Income Difference
Pharma Foods International Co., Ltd. 5.11 Billion JPY 113.64%
Takeda Pharmaceutical Company Limited 214.07 Billion JPY 100.326%
Sumitomo Pharma Co., Ltd. -354.19 Billion JPY 99.803%
Shionogi & Co., Ltd. 171.46 Billion JPY 100.407%
Wakamoto Pharmaceutical Co.,Ltd. -195.51 Million JPY -256.725%
Nippon Shinyaku Co., Ltd. 31.38 Billion JPY 102.222%
Kaken Pharmaceutical Co., Ltd. 9.51 Billion JPY 107.331%
Eisai Co., Ltd. 53.4 Billion JPY 101.306%
Morishita Jintan Co., Ltd. 716 Million JPY 197.407%
Hisamitsu Pharmaceutical Co., Inc. 13.16 Billion JPY 105.297%
Mochida Pharmaceutical Co., Ltd. 5.8 Billion JPY 112.019%
Fuso Pharmaceutical Industries,Ltd. 1.96 Billion JPY 135.511%
Nippon Chemiphar Co., Ltd. -494 Million JPY -41.182%
Tsumura & Co. 20.01 Billion JPY 103.484%
Kissei Pharmaceutical Co., Ltd. 4.01 Billion JPY 117.362%
Torii Pharmaceutical Co., Ltd. 5.03 Billion JPY 113.849%
Towa Pharmaceutical Co., Ltd. 17.64 Billion JPY 103.952%
Fuji Pharma Co., Ltd. 3.85 Billion JPY 118.078%
Zeria Pharmaceutical Co., Ltd. 9.71 Billion JPY 107.178%
KYORIN Holdings, Inc. 6.01 Billion JPY 111.599%
Taiko Pharmaceutical Co.,Ltd. -3.07 Billion JPY 77.349%
Daito Pharmaceutical Co.,Ltd. 3.89 Billion JPY 117.911%
SymBio Pharmaceuticals Limited -811.66 Million JPY 14.074%
MedRx Co., Ltd -933 Million JPY 25.248%
Mizuho Medy Co.,Ltd. 5.15 Billion JPY 113.537%
Solasia Pharma K.K. -1.13 Billion JPY 38.768%
Modalis Therapeutics Corporation -2.37 Billion JPY 70.572%
ASKA Pharmaceutical Holdings Co.,Ltd. 6.5 Billion JPY 110.73%
Sawai Group Holdings Co., Ltd. 18.88 Billion JPY 103.693%
Toho Holdings Co., Ltd. 19.33 Billion JPY 103.608%
Koa Shoji Holdings Co.,Ltd. 4.38 Billion JPY 115.915%